CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 259 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,167 | -15.6% | 75,369 | -13.1% | 0.08% | -23.3% |
| Q1 2024 | $1,382 | -9.2% | 86,702 | -4.2% | 0.10% | +3.0% |
| Q4 2023 | $1,522 | +33.6% | 90,512 | -7.1% | 0.10% | +31.6% |
| Q3 2023 | $1,139 | +246.2% | 97,395 | +297.4% | 0.08% | +245.5% |
| Q2 2023 | $329 | -100.0% | 24,505 | -81.2% | 0.02% | -57.7% |
| Q3 2021 | $689,000 | +108.2% | 130,000 | +126.1% | 0.05% | +160.0% |
| Q2 2021 | $331,000 | – | 57,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |